Current financial headlines
Financial news from across the world, newest first. Choose a country or market group, open the source, or continue into the company data.
TradingView Earnings
Chronological news
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
Henry Schein has delivered a 30.7% share price gain over the past year, which naturally puts the spotlight on whether that move is backed by the cash the business is expected to generate. With the stock recently closing at US$86.37, the key issue now โฆ
This article provides a detailed profile of the Cencora, Inc. bond (ABC5156681), highlighting key facts such as its issuer, issue and maturity dates, face value, and minimum denomination. It also details the bond's interest payment schedule, including a 2.70% semi-annual fixed rate coupon, and โฆ
In the latest trading session, Cardinal Health (CAH) closed at $220.22, marking a -1.08% move from the previous day. This move lagged the S&P 500's daily gain of 0.51%. Meanwhile, the Dow experienced a rise of 0.93%, and the technology-dominated Nasdaq saw an increase โฆ
McKesson (MCK) is back in focus after its share price dipped 1.2%, trailing the broader market, as investors weigh mixed earnings estimates against the company's raised full-year adjusted EPS guidance and specialty-led healthcare footprint. Recent trading has been choppy for McKesson, with the share โฆ
This article reports on Cencora Inc.'s Form 8K filing for September 25. The content is very brief, serving primarily as a notification of the SEC filing. It also includes market data for various indices, commodities, and stocks.
Cencora Inc. (NYSE: COR) has appointed Robert E. Sanchez, former CEO of Ryder System, as an independent director, effective October 1, 2026. Sanchez brings extensive experience in logistics, supply chain, operations, and finance, which is highly relevant to Cencora's pharmaceutical distribution business. His background โฆ
Cencora, Inc. has announced the appointment of Robert E. Sanchez to its Board of Directors as an independent director, effective October 1, 2026. Sanchez previously served as Executive Chair, and prior to that, as Chair and Chief Executive Officer of Ryder System, Inc. He โฆ
This article from Investing.com reports on Cencora Inc.'s Form 8K filing for September 25. The content indicates it's a standard notification of a corporate event, without providing specific details about the 8K filing itself. It briefly mentions the company's stock symbol COR and its โฆ
Cencora, Inc. (NYSE:COR) has announced the appointment of Robert E. Sanchez, former Chair and CEO of Ryder System, Inc., as an independent director to its Board, effective October 1, 2026. Sanchez's extensive experience in logistics, supply chains, operations, finance, and technology is expected to โฆ
CONSHOHOCKEN, Pa., September 25, 2026--(BUSINESS WIRE)--Cencora, Inc. (NYSE: COR) today announced that its Board of Directors has elected Robert E. Sanchez as a new independent director, effective October 1, 2026. Mr. Sanchez is the Executive Chair of Ryder System, Inc., where he previously served โฆ
Cencora (COR) has announced the appointment of Robert E. Sanchez to its Board of Directors, effective October 1, 2026. This appointment increases the board size from ten to eleven members. Sanchez will receive the same benefits and compensation as other non-employee directors, with his โฆ
Cardinal Health (CAH) has seen significant stock growth, with a 383.8% return over the past five years, leading to a current share price of US$222.04. The article examines whether the company's earnings justify this valuation, noting that CAH trades at a higher P/E ratio โฆ
Accendra Health, formerly Owens & Minor, saw its stock fall after its corporate transition and a Q2 EPS miss. The company completed a $375 million sale of its Products & Healthcare Services segment and the Owens & Minor brand, changing its name and ticker โฆ
Cencora stock closed flat at USD 312.28 on September 24, 2026, on the NYSE, while the S&P 500 slipped slightly. The article details Cencora's stock performance for the prior day, including trading range and volume. It also mentions upcoming US economic data scheduled for โฆ
McKesson stock closed with a 0.1 percent gain on September 24, 2026, outperforming the S&P 500, which slipped by 1.90 points. The healthcare sector generally performed well during the session. Upcoming economic calendar items for September 25, 2026, including core durable goods orders, are โฆ
Cardinal Health is shifting its focus towards specialty pharmaceuticals and higher-value healthcare services, including its role in the expanding medical textile sector. While this strategy aims to boost earnings and margins, investors need to monitor execution risk, input costs, and potential quality control issues. โฆ
Cardinal Health stock saw a 0.4 percent gain on September 24, 2026, closing at USD 178.42, while the Nasdaq Composite fell 1.1 percent. This performance marked a 1.5 percentage point outperformance for Cardinal Health compared to the reference index. The healthcare sector generally outperformed, โฆ
This article announces the filing of Form 4 for Accendra Health Inc. on September 24. It is a brief, one-sentence notification published by Investing.com, providing basic information about a financial filing. The content focuses solely on this announcement without further elaboration.
Accendra Health Inc. (ACH) EVP & CFO Leon Jonathan A surrendered 4,265 shares on September 23, 2026, to cover tax withholding obligations related to the vesting of restricted stock. The shares were valued at $0.85 each. Following this transaction, Jonathan A. Leon directly holds โฆ
Cardinal Health CAH and McKesson MCK are direct competitors in U.S. pharmaceutical distribution, with both increasingly leveraging specialty pharmaceuticals, provider platforms and technology to expand beyond traditional distribution. CAH's core momentum is anchored by Pharmaceutical and Specialty Solutions, supported by at-Home Solutions, Nuclear and โฆ
Sharemaestro market context Trend signal started 52 weeks +17.8% ยท Next-week setup positive 64.8%Cardinal Health has been a powerful performer over the past several years. The question now is whether the current share price lines up with what the business is earning. With the stock pulling back slightly in the short term after a strong multi year โฆ
McKesson stock reported adjusted EPS of USD 9.93 in Q1 fiscal 2027, exceeding consensus estimates by 5.2 percent, and revenue of USD 105.38 billion, an 8 percent year-over-year increase. The company raised its fiscal 2027 adjusted EPS guidance to USD 44.20-45.00, reflecting continued strong โฆ
Cardinal Health stock saw a 1.47 percent increase on the NYSE, reaching USD 224.52, following a strong fiscal year 2026 with revenues of USD 254.2 billion, up 14 percent. The company issued adjusted EPS guidance of USD 12.40 to USD 12.60 for fiscal 2027, โฆ
McKesson (NYSE: MCK) has achieved an impressive average annual return of 34.23% over the last five years, significantly outperforming the broader market by 22.21% annually. An initial investment of $100 five years ago would now be worth $431.70, showcasing the power of compounded returns. โฆ
McKesson stock (US58155Q1031) closed at USD 896.22 on September 22, 2026, marking a 1.10 percent gain on the NYSE, outperforming the Nasdaq Composite. The trading volume was 120,517 shares, significantly lower than the average. The company is set to release its second-quarter fiscal 2027 โฆ
Search by ticker symbol or company name and select a result to open its chart.
Start typing to find a stock or ETF.
Choose one or more countries for market search, or include every covered market.
Currently searching United States